151 related articles for article (PubMed ID: 33676787)
1. The nerve injuries attenuate the persistence of psoriatic lesions.
Qin B; Sun C; Chen L; Wang S; Yang J; Xie Z; Shen Z
J Dermatol Sci; 2021 May; 102(2):85-93. PubMed ID: 33676787
[TBL] [Abstract][Full Text] [Related]
2. Suppression of neuropeptide by botulinum toxin improves imiquimod-induced psoriasis-like dermatitis via the regulation of neuroimmune system.
Amalia SN; Uchiyama A; Baral H; Inoue Y; Yamazaki S; Fujiwara C; Sekiguchi A; Yokoyama Y; Ogino S; Torii R; Hosoi M; Ishikawa O; Motegi SI
J Dermatol Sci; 2021 Jan; 101(1):58-68. PubMed ID: 33176965
[TBL] [Abstract][Full Text] [Related]
3. Anti-IL-17A and IL-23p19 antibodies but not anti-TNFα antibody induce expansion of regulatory T cells and restoration of their suppressive function in imiquimod-induced psoriasiform dermatitis.
Shimizu T; Kamata M; Fukaya S; Hayashi K; Fukuyasu A; Tanaka T; Ishikawa T; Ohnishi T; Tada Y
J Dermatol Sci; 2019 Sep; 95(3):90-98. PubMed ID: 31362906
[TBL] [Abstract][Full Text] [Related]
4. GPR15 is not critically involved in the regulation of murine psoriasiform dermatitis.
Sezin T; Kempen L; Meyne LM; Mousavi S; Zillikens D; Sadik CD
J Dermatol Sci; 2019 Apr; 94(1):196-204. PubMed ID: 30935778
[TBL] [Abstract][Full Text] [Related]
5. IL-22 is required for imiquimod-induced psoriasiform skin inflammation in mice.
Van Belle AB; de Heusch M; Lemaire MM; Hendrickx E; Warnier G; Dunussi-Joannopoulos K; Fouser LA; Renauld JC; Dumoutier L
J Immunol; 2012 Jan; 188(1):462-9. PubMed ID: 22131335
[TBL] [Abstract][Full Text] [Related]
6. Fingolimod ameliorates imiquimod-induced psoriasiform dermatitis by sequestrating interleukin-17-producing ?d T cells in secondary lymph nodes.
Okura I; Kamata M; Asano Y; Mitsui A; Shimizu T; Sato S; Tada Y
J Dermatol Sci; 2021 May; 102(2):116-125. PubMed ID: 33888401
[TBL] [Abstract][Full Text] [Related]
7. Surgical Denervation in the Imiquimod-Induced Psoriasiform Mouse Model.
Onderdijk AJ; Hekking-Weijma IM; Florencia EF; Prens EP
Methods Mol Biol; 2017; 1559():75-81. PubMed ID: 28063038
[TBL] [Abstract][Full Text] [Related]
8. Cutaneous denervation of psoriasiform mouse skin improves acanthosis and inflammation in a sensory neuropeptide-dependent manner.
Ostrowski SM; Belkadi A; Loyd CM; Diaconu D; Ward NL
J Invest Dermatol; 2011 Jul; 131(7):1530-8. PubMed ID: 21471984
[TBL] [Abstract][Full Text] [Related]
9. Inhibiting Protein Kinase Activity of Pyruvate Kinase M2 by SIRT2 Deacetylase Attenuates Psoriasis.
Hao L; Park J; Jang HY; Bae EJ; Park BH
J Invest Dermatol; 2021 Feb; 141(2):355-363.e6. PubMed ID: 32679047
[TBL] [Abstract][Full Text] [Related]
10. Calcipotriol and betamethasone dipropionate exhibit different immunomodulatory effects on imiquimod-induced murine psoriasiform dermatitis.
Takeoka S; Shimizu T; Kamata M; Hau CS; Fukaya S; Hayashi K; Fukuyasu A; Tanaka T; Ishikawa T; Ohnishi T; Tada Y
J Dermatol; 2020 Feb; 47(2):155-162. PubMed ID: 31762070
[TBL] [Abstract][Full Text] [Related]
11. Is CCR6 Required for the Development of Psoriasiform Dermatitis in Mice?
Yu S; Wu X; Zhou Y; Han D; Anderson LS; Simon SI; Hwang ST; Imai Y
J Invest Dermatol; 2019 Feb; 139(2):485-488. PubMed ID: 30193756
[No Abstract] [Full Text] [Related]
12. Ghrelin protects against contact dermatitis and psoriasiform skin inflammation by antagonizing TNF-α/NF-κB signaling pathways.
Qu R; Chen X; Hu J; Fu Y; Peng J; Li Y; Chen J; Li P; Liu L; Cao J; Wang W; Qiu C; Guo L; Vasilev K; Chen J; Zhou G; Li W; Zhao Y
Sci Rep; 2019 Feb; 9(1):1348. PubMed ID: 30718736
[TBL] [Abstract][Full Text] [Related]
13. Reducing Flightless I expression decreases severity of psoriasis in an imiquimod-induced murine model of psoriasiform dermatitis.
Chong HT; Yang GN; Sidhu S; Ibbetson J; Kopecki Z; Cowin AJ
Br J Dermatol; 2017 Mar; 176(3):705-712. PubMed ID: 27373931
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathologic overlap of psoriasis, eczema, and psoriasiform dermatoses: A retrospective study of T helper type 2 and 17 subsets, interleukin 36, and β-defensin 2 in spongiotic psoriasiform dermatitis, sebopsoriasis, and tumor necrosis factor α inhibitor-associated dermatitis.
Cohen JN; Bowman S; Laszik ZG; North JP
J Am Acad Dermatol; 2020 Feb; 82(2):430-439. PubMed ID: 31859047
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of interleukin-2-inducible T-cell kinase causes reduction in imiquimod-induced psoriasiform inflammation through reduction of Th17 cells and enhancement of Treg cells in mice.
Nadeem A; Ahmad SF; Al-Harbi NO; Ibrahim KE; Alqahtani F; As Sobeai HM; Alotaibi MR
Biochimie; 2020 Dec; 179():146-156. PubMed ID: 33007409
[TBL] [Abstract][Full Text] [Related]
16.
Bezdek S; Leng L; Busch H; Mousavi S; Rades D; Dahlke M; Zillikens D; Bucala R; Sadik CD
Front Immunol; 2018; 9():2262. PubMed ID: 30333830
[TBL] [Abstract][Full Text] [Related]
17. Single-cell RNA-Seq reveals the transcriptional landscape and heterogeneity of skin macrophages in Vsir
Qie C; Jiang J; Liu W; Hu X; Chen W; Xie X; Liu J
Theranostics; 2020; 10(23):10483-10497. PubMed ID: 32929361
[No Abstract] [Full Text] [Related]
18. Diet-induced obesity exacerbates imiquimod-mediated psoriasiform dermatitis in anti-PD-1 antibody-treated mice: Implications for patients being treated with checkpoint inhibitors for cancer.
Yu S; Wu X; Shi Z; Huynh M; Jena PK; Sheng L; Zhou Y; Han D; Wan YY; Hwang ST
J Dermatol Sci; 2020 Mar; 97(3):194-200. PubMed ID: 32044178
[TBL] [Abstract][Full Text] [Related]
19. Liver fibrosis is associated with cutaneous inflammation in the imiquimod-induced murine model of psoriasiform dermatitis.
Vasseur P; Pohin M; Jégou JF; Favot L; Venisse N; Mcheik J; Morel F; Lecron JC; Silvain C
Br J Dermatol; 2018 Jul; 179(1):101-109. PubMed ID: 29150843
[TBL] [Abstract][Full Text] [Related]
20. Effect of γ-secretase inhibitor on Th17 cell differentiation and function of mouse psoriasis-like skin inflammation.
Ma L; Xue H; Qi R; Wang Y; Yuan L
J Transl Med; 2018 Mar; 16(1):59. PubMed ID: 29523162
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
